APA (7th ed.) Citation

RM, C., F, Z., KD, M., MJ, L., RL, P., KL, S., . . . JA, S. (2021). E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(28), 3171. https://doi.org/10.1200/JCO.21.00944

Chicago Style (17th ed.) Citation

RM, Connolly, et al. "E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 39, no. 28 (2021): 3171. https://doi.org/10.1200/JCO.21.00944.

MLA (9th ed.) Citation

RM, Connolly, et al. "E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 39, no. 28, 2021, p. 3171, https://doi.org/10.1200/JCO.21.00944.